Header Logo

Connection

JASON ROBERT WESTIN to Administration, Oral

Back to Details
This is a "connection" page, showing publications JASON ROBERT WESTIN has written about Administration, Oral.
JASON ROBERT WESTIN
Connection Strength
0.023
Administration, Oral
  1. Combination of ibrutinib with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) for treatment-naive patients with CD20-positive B-cell non-Hodgkin lymphoma: a non-randomised, phase 1b study. Lancet Oncol. 2014 Aug; 15(9):1019-26.
    View in: PubMed
    Score: 0.023
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.